Active NRT vs placebo ‐ rs2036527 ‐ non‐Hispanic black or African American
End of treatment ‐ heterozygous or homozygous minor · people who smoke
Active NRT showed no clear difference in end of treatment ‐ heterozygous or homozygous minor compared with placebo ‐ rs2036527 ‐ non‐Hispanic black or African American (moderate certainty).
1 finding from 1 review
- Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers 2017 · Cochrane Headline outcomes onlyRR 0.89 [0.55, 1.46]2 studies · 283 participantsModerate